Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-29 5:1:46 am | VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update | GlobeNewsWire |
| 2024-02-27 5:0:0 am | VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium | GlobeNewswire |
| 2024-02-21 5:0:0 am | VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference | GlobeNewswire |
| 2024-02-02 2:50:33 am | Favourable Signals For VYNE Therapeutics: Numerous Insiders Acquired Stock | Simply Wall St. |
| 2024-01-10 5:0:0 am | VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo | GlobeNewswire |
| 2024-01-03 5:0:0 am | VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information